Coral Laboratories Ltd.
| BSE: 524506 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE683E01017 |
| BSE 00:00 | 23 Jul | 430.60 |
5.85 (1.38%) |
OPEN
432.00 |
HIGH
432.00 |
LOW
423.60 |
| NSE 05:30 | 01 Jan | Coral Laboratories Ltd |
| OPEN | 432.00 |
| PREVIOUS CLOSE | 424.75 |
| VOLUME | 1351 |
| 52-Week high | 582.30 |
| 52-Week low | 205.00 |
| P/E | 11.35 |
| Mkt Cap.(Rs cr) | 154 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Coral Laboratories Ltd. (CORALLABS) - Company Information
Coral Laboratories Ltd
Coral Laboratories Limited has been promoted by Navin B Doshi of the DWD group. The Company is spearheaded by Kishor R Mehta as Executive Director. CLL produces various pharmaceutical formulations. To Manufacture pharmaceutical formulations like tabletscapsules the company went into public issue in March 94 at a total cost of Rs.2.5 crores. The project has been completed successfully CLL plans to ...> More
| COMPANY INFORMATION | |||||||
| Independent Director : | Sheela R Kamdar | ||||||
| Whole-time Director : | Girish Dhameja | ||||||
| Independent Director : | Sanket Mehta | ||||||
| Director & CFO : | Sushma Shashi Kadkade | ||||||
| Additional Director : | Purvi Doshi | ||||||
| Addtnl Independent Director : | Saurabh Shah | ||||||
| Company Secretary : | Ruchi Anjaria | ||||||
| Additional Director : | Malay Doshi | ||||||
| AUDITOR : | M A Parekh & Associates/SPVM & Co | ||||||
| IND NAME : | Pharmaceuticals - Indian - Formulations | ||||||
| HOUSE NAME : | Coral | ||||||
| Registered office | |||||||
| SF-206 Silver Oak Complex, BPC Road,Vadodara,Gujarat-390020 | |||||||
| Ph : 91-022-2500 5245/46 | |||||||
| WEBSITE : http://www.corallab.com | |||||||
| E-mail : cs@corallab.com | |||||||
Quick Links for Coral Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
